Antibody

1,032개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,032 programs
AntibodyLimited DatastaleBeiGenePhase 2

atezolizumab (Tecentriq, Tislelizumab/Atezolizumab/ Durvalumab/Benmelstobart/Toripalimab/Serplulimab)

Extensive Stage Lung Small Cell Cancer · Extensive Stage Lung Small Cell Cancer

#ExtensiveStageLungSmallCellCance#Antibody#Phase2#monoclonal-antibody#BeiGene
Trials 2Status Recruiting
AntibodyLimited DatastaleShanghai Kechow Pharma, Inc.Phase 2

Tunlametinib+PD-1 mAb (Tunlametinib+PD-1 mAb)

Gastric Adenocarcinoma · PD-1

#PD-1#Antibody#Phase2#monoclonal-antibody#GastricAdenocarcinoma+1
Trials 2Status Recruiting
AntibodyLimited DatastaleRochePhase 1

trastuzumab (Herceptin, US sourced Herceptin®)

Healthy · Healthy

#Healthy#Antibody#Phase1#monoclonal-antibody#Roche
Trials 2Status Active
AntibodyLimited DatastaleXencor, Inc.Phase 2

XmAb18087 (XmAb18087)

Merkel Cell Carcinoma; Small Cell Lung Cancer · Merkel Cell Carcinoma

#MerkelCellCarcinoma#Antibody#Phase2#monoclonal-antibody#SmallCellLungCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleXencor, Inc.Phase 1

XmAb541 (XmAb541)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase1#monoclonal-antibody#Xencor
Trials 2Status Recruiting
AntibodyCurated CorestaleRocheApproved

Xolair (Xolair)

Atopic Eczema; Atopic Dermatitis · Chronic Spontaneous Urticaria

#ChronicSpontaneousUrticaria#Antibody#Approved#BioJungboMoa-pick#monoclonal-antibody+3
Trials 2Status Active
AntibodyLimited DatastaleRochePhase 2

atezolizumab (Tecentriq, YL201 and atezolizumab)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#monoclonal-antibody#Roche
Trials 2Status Recruiting
AntibodyLimited DatastaleGenmabPhase 2

Zalutumumab (Zalutumumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#Genmab
Trials 2Status Active
AntibodyLimited DatastaleAmgenPhase 1

acapatamab (acapatamab)

Metastatic Castration-resistant Prostate Cancer; Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#Antibody#Phase1#monoclonal-antibody#ProstateCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastaleNeovii BiotechPhase 2

ertumaxomab (ertumaxomab)

Metastatic Breast Cancer; Advanced Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#Antibody#Phase2#monoclonal-antibody#AdvancedBreastCancer+1
Trials 2Status Discontinued
AntibodyLimited DatastalePETHEMA FoundationPhase 2

ibritumomab tiuxetan (ibritumomab tiuxetan)

Lymphoma · FRα

#FR#Antibody#Phase2#monoclonal-antibody#Lymphoma+1
Trials 2Status Discontinued
AntibodyLimited DatastaleEli LillyPhase 2

mCapOX plus Cetuximab (mCapOX plus Cetuximab)

Colo-rectal Cancer; Capecitabine · Colorectal Cancer (CRC)

#ColorectalCancerCRC#Antibody#Phase2#monoclonal-antibody#Colo-rectalCancer+2
Trials 2Status Active
AntibodyLimited DatastaleRadboud University Medical Cent…Preclinical

111Indium-bevacizumab (111Indium-bevacizumab)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#Antibody#Preclinical#monoclonal-antibody#Radboud
Trials 1Status Active
AntibodyLimited DatastaleColumbia UniversityPhase 1

131I-apamistmab (131I-apamistmab)

Sickling Disorder Due to Hemoglobin S · Sickling Disorder Due to Hemoglobin S

#SicklingDisorderDuetoHemoglobinS#Antibody#Phase1#monoclonal-antibody#Columbia
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: filgotinib 2: ustekinumab 3: vedolizumab 4: infliximab))

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: infliximab 2: filgotinib 3: ustekinumab 4: vedolizumab)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: ustekinumab 2: vedolizumab 3: infliximab 4: filgotinib)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleJanssenApproved

ustekinumab (Stelara, 1: vedolizumab 2: infliximab 3: filgotinib 4: ustekinumab)

Ulcerative Colitis (UC) · Ulcerative Colitis (UC)

#UlcerativeColitisUC#Antibody#Approved#monoclonal-antibody#Janssen
Trials 1Status Recruiting
AntibodyLimited DatastaleCentre Leon BerardPhase 2

atezolizumab (Tecentriq, 2 cycles of atezolizumab followed by surgery then post-operative radiotherapy)

Sarcoma,Soft Tissue · Sarcoma,Soft Tissue

#SarcomaSoftTissue#Antibody#Phase2#monoclonal-antibody#Sarcoma+2
Trials 1Status Recruiting
AntibodyLimited DatastaleMerckPhase 2

pembrolizumab (Keytruda, 89Zr-Pembrolizumab)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase2#monoclonal-antibody#Merck
Trials 1Status Active

16 / 52 pages

← PreviousNext →